Skip to main content
OpenTrials
Completed

NCT Number: NCT07104773

Clinical Investigation of Proclear® 1 Day and MyDay® Sphere Contact Lenses

The aim of this study is to evaluate and compare the performance of two soft contact lenses.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre for Ocular Research & Education

Waterloo, Ontario, N2L 3G1, Canada

About this study

The aim of this study is to evaluate and compare the performance of a hydrogel lens and a silicone hydrogel lens in existing soft lens wearers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Are at least 18 years of age and have capacity to consent;
  • Have understood and signed an information consent form;
  • Are an adapted soft contact lens wearer (worn for at least 3 months);
  • Have a contact lens prescription of -1.00DS to -6.00DS (inclusive) in each eye;
  • Have a refraction with a cylinder component of no more than -0.75DC in each eye;
  • Can achieve a best spectacle-corrected visual acuity in each eye of +0.10 logMAR or better.

Exclusion criteria

  • Participation in a contact lens or contact lens care product clinical trial in the previous 30 days;
  • Have any known active anterior segment disease and/or infection or slit lamp findings that would contraindicate contact lens wear;
  • Have a systemic condition that would contraindicate contact lens wear;
  • Are using any systemic or topical medications that would contraindicate contact lens wear;
  • Have known sensitivity to the diagnostic fluorescein sodium to be used in the study;
  • Are an employee of the study site (Centre for Ocular Research & Education) and directly involved in the study (ie. on the delegation log).

Treatment and study plan

Control Lens (omafilcon A)

Device

15 minutes of daily wear

Test Lens (stenfilcon A)

Device

15 minutes of daily wear

Primary outcomes

  1. Subjective Comfort Rating

    Time frame: At the end of 15 minutes of daily wear

    The primary outcome of this study is lens comfort on a scale of 0-100 (0= worst, 100=best).

Sponsors and collaborators

Lead sponsor

CooperVision International Limited (CVIL)

Industry

Collaborators

  • Centre for Ocular Research & Education, Canada

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Aug 5, 2025
Registry last updated
Apr 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.